Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: A clinical trial

Nutrition

Volumn 29, Issue 7-8, 2013, Pages 977-981

  Corrêa, Telma A F ^a   Rogero, Marcelo M ^a   Mioto, Bruno M ^a   Tarasoutchi, Daniela ^a   Tuda, Vera L ^a   César, Luiz A M ^a   Torres, Elizabeth A F S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antioxidants; Cardiovascular disease; Cholesterol; Coffee; Endothelial dysfunction; Inflammation; Risk factors

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ADVERSE OUTCOME; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COFFEE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOOD INTAKE; FOOD PROCESSING; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PAPER FILTERED COFFEE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COFFEE; CROSS-OVER STUDIES; E-SELECTIN; FEMALE; FIBRINOGEN; FILTRATION; FOOD HANDLING; HEALTHY VOLUNTEERS; HOMOCYSTEINE; HUMANS; INFLAMMATION; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84879004811     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.01.003     Document Type: Article

References (33)

1. Bohn S.K., Ward N.C., Hodgson J.M., Croft K.D. Effects of tea and coffee on cardiovascular disease risk. Food Funct 2012, 3:575-591.
2. Mineharu Y., Koizumi A., Wada Y., Iso H., Watanabe Y., Date C., et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 2011, 65:230-240.
3. de Koning Gans J.M., Uiterwaal C.S.P.M., van der Schouw Y.T., Boer J., Grobbee D.E., Verschuren W.M., et al. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol 2010, 30:1665-1671.
4. Kempf K., Herder C., Erlund I., Kolb H., Martin S., Carstensen M., et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 2010, 91:950-957.
5. Butt M.S., Sultan M.T. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr 2011, 51:363-373.
6. Ranheim T., Halvorsen B. Coffee consumption and human health-beneficial or detrimental?-Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 2005, 49:274-284.
7. Van Dieren S., Uiterwaal C.S.P.M., Van der Schouw Y.T., van der A.D.L., Boer J.M.A., Spijkerman A., et al. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia 2009, 52:2561-2569.
8. Yamaguchi T., Chikama A., Mori K., Watanabe T., Shioya Y., Katsuragi Y., et al. Hydroxyhydroquinone-free coffee: a double-blind, randomized controlled dose-response study of blood pressure. Nutr Metabol Cardiovasc Dis 2008, 18:408-414.
9. Medina-Remón A., Zamora-Ros R., Rotchés-Ribalta M., Andres-Lacueva C., Martínez-González M.A., Covas M.I., et al. Total polyphenol excretion and blood pressure in subjects at high cardiovascular risk. Nutr Metabol Cardiovasc Dis 2010, 21:323-331.
10. Thelle D.S., Strandhagen E. Coffee and disease: an overview with main emphasis on blood lipids and homocysteine. Scand J Food Nutr 2005, 49:50-61.
11. Strandhagen E., Thelle D.S. Filtered coffee raises serum cholesterol: results from a controlled study. Eur J Clin Nutr 2003, 57:1164-1168.
12. Andersen L.F., Jacobs D.R., Carlsen M.H., Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006, 83:1039-1046.
13. Freedman N.D., Park Y., Abnet C.C., Hollenbeck A.R., Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012, 366:1891-1904.
14. Zampelas A., Panagiotakos D.B., Pitsavos C., Chrysohoou C., Stefanadis C. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 2004, 80:862-867.
15. Lopez-Garcia E., van Dam R.M., Qi L., Hu F.B. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006, 84:888-893.
16. Jaiswal R., Patras M.A., Eravuchira P.J., Kuhnert N. Profile and characterization of the chlorogenic acids in green robusta coffee beans by LC-MSn: identification of seven new classes of compounds. J Agric Food Chem 2010, 58:8722-8737.
17. Silva J.A., Borges N., Santos A., Alves A. Method validation for cafestol and kahweol quantification in coffee brews by HPLC-DAD. Food Anal Methods 2012, 5:1404-1410.
18. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Wallace T.M., Levy J.C., Matthews D.R. Use and abuse of HOMA modeling. Diabetes care 2004, 27:1487-1495.
21. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957, 17:237-246.
22. NCEP Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106:3143-3421.
23. Burke M.F., Khera A.V., Rader D.J. Polyphenols and cholesterol efflux is coffee the next red wine?. Circ Res 2010, 106:627-629.
24. Sridevi V., Giridhar P., Ravishankar G.A. Evaluation of roasting and brewing effect on antinutritional diterpenes-cafestol and kaweol in coffee. Global J Med Res 2011, 11:17-22.
25. Naidoo N., Chen C., Rebello S.A., Speer K., Tai E.S., Lee J., et al. Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: a survey and cross sectional study. Nutr J 2011, 10:48.
26. Zhang C., Linforth R., Fisk I.D. Cafestol extraction yield from different coffee brew mechanisms. Food Res Int 2012, 49:27-31.
27. Jee S.H., He J., Appel L.J., Whelton P.K., Suh I.I., Klag M.J. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001, 153:353-362.
28. Cai L., Ma D., Zhang Y., Liu Z., Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. Eur J Clin Nutr 2012, 66:872-877.
29. Ricketts M.L., Boekschoten M.V., Kreeft A.J., Hooiveld G.J.E.J., Moen C.J.A., Müller M., et al. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol 2007, 21:1603-1616.
30. Fried R.E., Levine D.M., Kwiterovich P.O., Diamond E.L., Wilder L.B., Moy T.F., et al. The effect of filtered-coffee consumption on plasma lipid levels. JAMA 1992, 267:811-815.
31. Galkina E., Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007, 27:2292-2301.
32. Corrêa T.A.F., Monteiro M.P., Mendes T.M., Oliveira D.M., Rogero M.M., Benites C.I., et al. Medium light and medium roast paper-filtered coffee increased antioxidant capacity in healthy volunteers: results of a randomized trial. Plant Foods Hum Nutr 2012, 67:277-282.
33. Kaptoge S., White I.R., Thompson S.G., Wood A.M., Lewington S., Lowe G.D., et al. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007, 166:867-879.